Mike Binder Mike Binder

mRNA Technology Conference - Purilogics by Donaldson Presenting Jinxiang Zhou, April 22 2024 at 11:40am

In this presentation, Purilogics by Donaldson introduces the concept of using high-performance membrane chromatography technologies to rapidly purify SC pDNA and mRNA. We will illustrate purifying SC pDNA by capture chromatography using Purexa™ NAEX Plus, a weak anion chromatography membrane, followed by a polishing step using Purexa™ MCP, a hydrophobic interaction chromatography membrane that has superior and consistent capability to separate SC pDNA from open circular pDNA. We will illustrate purifying mRNA using Purexa™ OdT, an affinity capture chromatography membrane targeting the Poly A tails in mRNA.

Read More
Purexa™ NAEX, Purexa™ MCP, Purexa™ OdT jeremy hogenbaum Purexa™ NAEX, Purexa™ MCP, Purexa™ OdT jeremy hogenbaum

On Demand Webinar on mRNA Purification from Purilogics by Donaldson

Listen to company co-founder, Jin Zhou on how Purexa™ NAEX+ and MCP demonstrates fast and efficient purification of super coiled DNA, as well as how Purexa™ OdT shows superior performance in mRNA/IVT Purification. Purilogics products provide solutions and are tailored for high-throughput nucleic acid purification. Listen to this webinar to learn how to increase mRNA purification production with novel membrane chromatography.

Read More
Purexa™ PrA Mike Binder Purexa™ PrA Mike Binder

High throughput purification of monoclonal recombinant antibodies using a Protein-A coated membrane plate system

Purilogics’ Jinxiang Zhou recently co-authored an article alongside Camila Leal-Lopes, Sara D’Angelo, Andre A.R. Teixeira, Andrew R.M Bradbury, Fortunato Ferrara, and M. Frank Erasmus – the Head of Bioinformatics at Specifica, Inc. We are excited to announce that this article has been published in the New Biotechnology Journal: High throughput purification of monoclonal recombinant antibodies using a Protein-A coated membrane plate system.

Read More
jeremy hogenbaum jeremy hogenbaum

A Vision of Future Gene Therapy: Non-Viral Nanovectors

Recent developments in research have highlighted the potential of non-viral nanoparticles as vectors in gene therapy. Gene therapy typically refers to the use of nucleic acids, such as plasmids and siRNA, to genetically modify patient’s cells.1 Traditionally, viral vectors have been pursued as gene delivery vehicles, but a variety of risks and problems associated with them have limited their large-scale use clinically.

Read More
jeremy hogenbaum jeremy hogenbaum

Antibody Fragment Booknotes (1)

How can Purilogics help? We offer membrane columns for small-scale antibody purification. Our mini and midi columns can be used with a syringe to purify small volumes of antibody.

Read More
Purexa™ PrA jeremy hogenbaum Purexa™ PrA jeremy hogenbaum

Purilogics to Present at Antibody Engineering & Therapeutics Conference

We’re excited to attend the Antibody Engineering & Therapeutics Conference in San Diego, CA from December 13th to 17th! Hosted by the Antibody Society, which is dedicated to the promotion of antibody research and development, this conference showcases the latest antibody technologies and science to accelerate next generation antibodies towards commercial success.

Read More
jeremy hogenbaum jeremy hogenbaum

mRNA Size — An Important Factor You Cannot Ignore

Over the past 18 months, there has been a sharp rise in interest concerning the development of mRNA-based therapies, as highlighted by the FDA’s Emergency Use Authorization and subsequent approval of one of two novel SARS-CoV-2 mRNA vaccines.

Read More